Incretin-Based Therapies: Revisiting Their Mode of Action.

Arturo D Mancini, Gyslaine Bertrand, Kevin Vivot, Éric Carpentier, Caroline Tremblay, Julien Ghislain, Michel Bouvier, Vincent Poitout, None, β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1. Journal of Biological Chemistry. ,vol. 290, pp. 21131- 21140 ,(2015) , 10.1074/JBC.M115.644450

Daniel J. Drucker, Steven I. Sherman, Richard M. Bergenstal, John B. Buse, The Safety of Incretin-Based Therapies—Review of the Scientific Evidence The Journal of Clinical Endocrinology and Metabolism. ,vol. 96, pp. 2027- 2031 ,(2011) , 10.1210/JC.2011-0599

W. M. Bayliss, E. H. Starling, The mechanism of pancreatic secretion The Journal of Physiology. ,vol. 28, pp. 325- 353 ,(1902) , 10.1113/JPHYSIOL.1902.SP000920

Jean B. Regard, Hiroshi Kataoka, David A. Cano, Eric Camerer, Liya Yin, Yao-Wu Zheng, Thomas S. Scanlan, Matthias Hebrok, Shaun R. Coughlin, Probing cell type–specific functions of Gi in vivo identifies GPCR regulators of insulin secretion Journal of Clinical Investigation. ,vol. 117, pp. 4034- 4043 ,(2007) , 10.1172/JCI32994

Michelle E. Kimple, Jamie W. Joseph, Candice L. Bailey, Patrick T. Fueger, Ian A. Hendry, Christopher B. Newgard, Patrick J. Casey, Gαz negatively regulates insulin secretion and glucose clearance Journal of Biological Chemistry. ,vol. 283, pp. 4560- 4567 ,(2008) , 10.1074/JBC.M706481200

T. Xie, M. Chen, Q.-H. Zhang, Z. Ma, L. S. Weinstein, β cell-specific deficiency of the stimulatory G protein α-subunit Gsα leads to reduced β cell mass and insulin-deficient diabetes Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 19601- 19606 ,(2007) , 10.1073/PNAS.0704796104

M. Nauck, F. Stöckmann, R. Ebert, W. Creutzfeldt, Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. ,vol. 29, pp. 46- 52 ,(1986) , 10.1007/BF02427280

Kenichiro Nakajima, Shalini Jain, Inigo Ruiz de Azua, Sara M. McMillin, Mario Rossi, Jürgen Wess, Minireview: Novel Aspects of M3 Muscarinic Receptor Signaling in Pancreatic β-Cells Molecular Endocrinology. ,vol. 27, pp. 1208- 1216 ,(2013) , 10.1210/ME.2013-1084

Riccardo Perfetti, Loredana Farilla, Hongxiang Hui, Cristina Bertolotto, Elizabeth Kang, Angela Bulotta, Umberto Di Mario, Glucagon-Like Peptide-1 Promotes Islet Cell Growth and Inhibits Apoptosis in Zucker Diabetic Rats Endocrinology. ,vol. 143, pp. 4397- 4408 ,(2002) , 10.1210/EN.2002-220405

M. Nauck, Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors Diabetes, Obesity and Metabolism. ,vol. 18, pp. 203- 216 ,(2016) , 10.1111/DOM.12591